An interdisciplinary team of researchers from North Carolina State University and the University of North Carolina at Chapel Hill has developed a smart patch designed to monitor a patient's blood and ...

We identified a novel mechanism of hereditary thrombosis associated with antithrombin resistance, with a substitution of arginine for leucine at position 596 (p.Arg596Leu) in the gene encoding ...

Molecular biologists have discovered a way to harness the enzyme thrombin's anti-blood clotting properties. In research led by a Saint Louis University investigator, molecular biologists have ...

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic ...

The developing thrombus in a living mouse after vessel-wall injury (Panel A) is characterized by the deposition of platelets (red), tissue factor (green), and fibrin (blue). Platelet thrombus ...

Immunothrombosis, or the formation of microscopic blood clots during inflammation, is a major cause of morbidity among patients with sepsis or severe COVID-19. A key enzyme in this process is thrombin ...